Association of Artificial Tears with Ocular and Systemic Infection: Carbapenem-resistant Pseudomonas aeruginosa (VIM-GES-CRPA) Outbreak
- PMID: 37452816
- PMCID: PMC11182435
- DOI: 10.1016/j.ophtha.2023.06.003
Association of Artificial Tears with Ocular and Systemic Infection: Carbapenem-resistant Pseudomonas aeruginosa (VIM-GES-CRPA) Outbreak
References
-
- Center for Preparedness and Response (CPR). Outbreak of Extensively Drug-resistant Pseudomonas aeruginosa Associated with Artificial Tears. 2023.
-
- Centers for Disease Control and Prevention. Outbreak of extensively drug-resistant pseudomonas aeruginosa associated with artificial tears, 2023. Available at: https://www.cdc.gov/hai/outbreaks/crpa-artificial-tears.html.
-
- Llamas M EzriCare and Delsam Artificial Tears Recall. Drugwatch. March 23, 2023. Available at: https://www.drug-watch.com/drugs/ezricare-artificial-tears/recall/#:~:te....
-
- U.S. Food and Drug Administration. FDA warns consumers not to purchase or use EzriCare Artificial Tears due to potential contamination; 2023. Available at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consume....
-
- Centers for Disease Control and Prevention. 2019 Antibiotic Resistance Threats Report; 2021. Available at: https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-re....
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous